Avidity Biosciences Inc (NASDAQ: RNA) Has Decreased By 0.31 Percent This Year. Is It A Better Buy Than Others?
Avidity Biosciences Inc (NASDAQ:RNA)’s traded shares stood at 0.55 million during the last session, with the company’s beta value hitting 0.93. At the close of